临床特征和急性乙性肺炎的结果:全国性的描述性研究
Tomohiro Akaba1,2, Yuya Kimura3, Mitsuko Kondo1
1Department of Respiratory Medicine, Tokyo Women's Medical University School of Medicine, Tokyo, Japan.
The World Allergy Organization journal
|December 1, 2025
概括
急性乙性肺炎 (AEP) 是一种罕见的肺部疾病. 这项研究发现,大多数AEP患者的短期结果很好,但氧气水平较低的患者需要更密集的护理.
科学领域:
- 肺部病理学 肺部病理学
- 关键护理医学 关键护理医学
- 流行病学 流行病学
背景情况:
- 急性乙性肺炎 (AEP) 是一种罕见但严重的肺部疾病,其特征是快速呼吸衰竭.
- 关于AEP在一般人群中的流行病学特征和临床结果的数据有限.
研究的目的:
- 通过使用全国数据库,调查急性性肺炎 (AEP) 患者的临床特征,治疗模式和结果.
- 在AEP中识别与疾病严重程度和治疗需求相关的因素.
主要方法:
- 使用日本诊断程序组合数据库 (2020年4月 - 2023年3月) 进行了一项全国性的回顾性研究.
- 用诊断码和支气管镜记录来识别患者.
- 对328名AEP患者的临床数据,治疗方法和结果进行了分析.
主要成果:
- AEP患者的平均年龄为46岁,其中63.7%是男性.
- 在入院时的缺氧在86.9%的患者中观察到.
- 系统性皮质类固醇被广泛使用 (96%),其中37.5%接受脉冲疗法. 在4.9%的病例中,机械通风是必要的.
- 住院死亡率低 (1.2%),住院时间中位数为11天.
- 入院时的缺氧与更长的住院时间以及增加皮质类固醇和抗生素的使用相关 (p < 0.001).
结论:
- 大多数患有急性乙性肺炎 (AEP) 的患者在短期内经历了有利的结果.
- 呈现缺氧的患者需要更密集的治疗策略.
- 没有报告与疾病相关的再入院,这表明出院患者的康复良好.
相关概念视频
01:29Pneumonia II: Pathophysiology
2.5K
The pathophysiology of pneumonia involves the following steps:
2.5K
01:30Pneumonia I: Introduction
702
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
702
01:30Pneumonia III: Complications and Assessment
762
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
762
01:28Pneumonia IV: Management
731
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
731
01:20COPD: Pathogenesis and Clinical Features
1.7K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.7K
01:22Chronic Obstructive Pulmonary Disease
2.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.2K